Organic compounds -- part of the class 532-570 series – Organic compounds – Nitrogen attached directly or indirectly to the purine ring...
Patent
1998-11-13
2000-07-25
Shah, Mukund J.
Organic compounds -- part of the class 532-570 series
Organic compounds
Nitrogen attached directly or indirectly to the purine ring...
C07D40314
Patent
active
060938226
ABSTRACT:
##STR1## wherein A, B, D, E, and F are each independently nitrogen or carbon; R.sub.1 is hydrogen, C.sub.1 to C.sub.6 alkyl, --(CH.sub.2).sub.n R.sub.7, or C.sub.1 to C.sub.3 alkyl-aryl; R.sub.2, R.sub.3, R.sub.4, R.sub.5 and R.sub.6 are each independently hydrogen, C.sub.1 to C.sub.6 alkyl, aryl, C.sub.1 to C.sub.3 alkyl-aryl, halogen, cyano, nitro, --(CH.sub.2).sub.m NR.sub.8 R.sub.9, --(CH.sub.2).sub.m OR.sub.9, --SR.sub.8, --SO.sub.2 NR.sub.8 R.sub.9, --(CH.sub.2).sub.m NR.sub.8 SO.sub.2 R.sub.9, --(CH.sub.2).sub.m NR.sub.8 CO.sub.2 R.sub.9, --(CH.sub.2).sub.m NR.sub.8 COR.sub.9, --(CH.sub.2).sub.m CONR.sub.7 R.sub.9, or --(CH.sub.2).sub.m CO.sub.2 R.sub.9 ; R.sub.2 and R.sub.3, R.sub.3 and R.sub.4, R.sub.4 and R.sub.5, and R.sub.5 and R.sub.6 may be taken together to form a five- to seven-membered alkyl ring, a six-membered ary ring, a five- to seven-membered heteroalkyl ring, having 1 heteroatom of N, O, or S, or a five- to six-membered heteroaryl ring having 1 or 2 heteroatoms of N, O, or S; R.sub.7 is --OR.sub.10, --SR.sub.10, --SO.sub.2 NR.sub.10 R.sub.11, --NR.sub.10 SO.sub.2 R.sub.11, --NR.sub.10 CO.sub.2 R.sub.11, --NR.sub.10 COR.sub.11, --CONR.sub.10 R.sub.11, or --CO.sub.2 R.sub.10 ; R.sub.8, R.sub.9, R.sub.10 and R.sub.11 are each independently hydrogen, C.sub.1 to C.sub.6 alkyl, or C.sub.1 to C.sub.3 alkyl-aryl; m is 0, 1, or 2; n is 2, 3, or 4; and the above aryl groups and the aryl moieties of the above alkyl-aryl groups are each independently phenyl or substituted phenyl, wherein said substituted phenyl may be substituted with one to three of C.sub.1 to C.sub.4 alkyl, halogen, hydroxy, cyano, carboxamido, nitro, or C.sub.1 to C.sub.4 alkoxy, and the pharmaceutically acceptable salts thereof. These compounds are useful in treating migraine and other disorders and are new. These compounds are useful psychotherapeutics and are potent serotonin (5-HT.sub.1) agonists and may be used in the treatment of depression, anxiety, eating disorders, obesity, drug abuse, cluster headache, migraine, pain, and chronic paroxysmal hemicrania and headache associated with vascular disorders, and other disorders arising from deficient serotonergic neurotransmission. The compounds can also be used as centrally acting antihypertensives and vasodilators.
REFERENCES:
patent: 2773875 (1956-12-01), Finkelstein
patent: 3037031 (1962-05-01), Lewis et al.
patent: 4252803 (1981-02-01), Webb
patent: 4803218 (1989-02-01), Stanley et al.
patent: 4855314 (1989-08-01), Oxford et al.
patent: 5208248 (1993-05-01), Baker et al.
patent: 5348968 (1994-09-01), Lavielle
patent: 5409941 (1995-04-01), Nowakowski
patent: 5498626 (1996-03-01), Macor
patent: 5502065 (1996-03-01), Brown et al.
patent: 5545644 (1996-08-01), Macor et al.
patent: 5559129 (1996-09-01), Macor et al.
patent: 5578612 (1996-11-01), Macor et al.
patent: 5594014 (1997-01-01), Macor et al.
patent: 5607951 (1997-03-01), Macor et al.
patent: 5607960 (1997-03-01), Wythes
patent: 5639752 (1997-06-01), Macor
patent: 5639779 (1997-06-01), Wythes et al.
patent: 5717102 (1998-02-01), Macor et al.
patent: 5747501 (1998-05-01), Macor et al.
patent: 5849739 (1998-12-01), Macor
Bader, et al.., J. Am Chem. Soc. 79, 5686-5689 (1957).
A.P. Gray, J. Org. Chem., 23, 1453-1454 (1958).
Moore, et al., J. Org. Chem., 20. 2860-2864 (1964).
Cain, et al., J. Am Chem. Soc., 105 908,911, 912 (1983).
Markowitz, et al. J. Neurosci, 7 (12) 4736 (1987).
Lee, et al., Brain Res., 626, 303-305 (1993).
P.P.A. Humphrey, et al., Br. J. Pharmacol, 94, 1128 (1988).
W. Fernik, et al., Br. J. Pharmacol, 96, 83 (1989).
Reggent for Org. Syn 1, 112 (1967).
Mohr, et al., Tetrahedron, 38(1), 147-152 (1982).
Friderichs, et al., Chem. Ab., 83, 28056 (1975).
Kiyooke, et al., J. Org. Chem, 5409 (1989).
Hamada, et al., Chem. Pharm. Bull., 1921 (1982).
Lee, et al., Soc. Neurosci Nov. 1993 Meeting 19 (Part 2), #565.6 (1993).
Moskowitz, 7th World Congress on Pain Aug. 1993, #667 (1993).
Leonard, et al., Neuropharm, 11, 373-384 (1972).
Fuller Jr. Grover F.
Ginsburg Paul H.
Pfizer Inc.
Rao Deepak R.
Richardson Peter C.
LandOfFree
5-arylindole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-arylindole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-arylindole derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1337535